Use of intravenous hydrocortisone in Henoch-Schonlein purpura

J Paediatr Child Health. 2001 Jun;37(3):309-10. doi: 10.1046/j.1440-1754.2001.00609.x.

Abstract

Henoch-Schonlein purpura should be considered in children with severe abdominal pain that is unresponsive to conventional treatment when no apparent cause is found on investigation. Such children may respond dramatically to a trial of intravenous corticosteroid and, hence, may avoid unnecessary investigations and laparotomy.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / etiology
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use*
  • Child, Preschool
  • Humans
  • Hydrocortisone / administration & dosage
  • Hydrocortisone / therapeutic use*
  • IgA Vasculitis / complications
  • IgA Vasculitis / diagnosis
  • IgA Vasculitis / drug therapy*
  • Injections, Intravenous
  • Male
  • Pain Measurement
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents
  • Hydrocortisone